Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP by Bag Type & Application The global single-use bioprocessing market will witness a robust CAGR of 15.86%, valued at $14.83 billion in 2021, expected to appreciate and reach $55.78 billion by 2030, confirms Strategic Market Research. As a result, the SMR Report covering market Forecast suggests that the market size will likely reach around USD 55.78 billion by 2030. North America held the most significant portion of the market share in 2021. Biopharmaceutical compounds such as recombinant proteins, monoclonal antibodies, vaccinations, and stem cells are manufactured using single-use bioprocessing equipment and accessories. According to the IFPMA (International Federation of Pharmaceutical Manufacturers & Associations), by the end of 2021, vaccine output was forecasted to reach 12.5 billion doses, then quadruple to 24 billion doses by June 2022, and hence the vaccine supply is expected to supersede the global demand. Bioprocesses use live cells or their components such as enzymes, bacteria, and others to obtain desired products. The major goal of incorporating single-use bioprocessing technology into the bioprocess is to reduce the costs of tasks like cleaning, sterilization, and maintenance of steel-based bioreactor systems. Market Drivers - Rise in the Geriatric Population, Increasing Demand for Biopharmaceuticals, Increasing Number of Biological Approvals According to U.N. Ageing Population Highlights, there were an anticipated 727 million people aged 65 and over in the world in 2020; by 2050, this number is expected to quadruple to 1.5 billion people. The need for biopharmaceuticals is predicted to rise due to the increase of the senior population in key markets, as the aged people are more susceptible to chronic illnesses and diseases. Companies increasingly select single-use bioprocessing systems to meet the growing demand for biopharmaceuticals. They boost the overall process efficiency and save expenses associated with daunting tasks like cleaning, sterilizing, and maintaining steel-based bioreactor systems. According to BioPharm International, Single-use bioprocessing infrastructure constitutes around 85% of pre-commercial biomanufacturing infrastructures. Many new technologies, such as automation, big data, and machine learning, are being used to meet the growing demand for pharmaceutical goods worldwide. According to the FDA(Food and Drug Administration), In 2018, 17 biologics were authorized, including 12 monoclonal antibodies (mAb), three pegylated enzymes, one protein, and one fusion protein. As a result, the rising number of biological approvals and patent expirations are predicted to boost the biopharmaceuticals manufacturing process, assisting in adopting single-use bioprocessing during the projection period. Filtration, purification, upstream expression, storage, and separation are just a few biopharmaceutical applications that leverage single-use bioprocessing technologies. As a result, the growing demand for biopharmaceuticals is propelling the market. Restraints - Issues Connected with Leachables and Extractables There are no specific laws to prevent extractable and leachable contaminating single-use bioprocessing systems. The Bio-Process Systems Alliance, on the other hand, has provided a comprehensive list of tests that may be done on single-use systems (BPSA). Under rigorous laboratory settings, extractables can be extracted from source materials using suitable solvents. Leachables, on the other hand, are chemicals that leak from containers, closures, and processing components and end up in medication products. Thus, due to their potential impacts on product quality and patient health, major concerns about extractables and leachables resulting from components of single-use bioprocessing systems may hamper the overall industry expansion across the globe. Market Trends & Opportunities - Increasing Spending in the Emerging Markets China, followed by India, is a high-potential market for single-use bioprocessing systems in the Asia-Pacific region. This is due to favourable government support, expanding private investment, a growing number of senior population, a significant rise of tendency to outsource to burgeoning Asian markets, and the availability of a competent workforce in these nations. According to a study issued by the National Bureau of Statistics, China's overall R&D expenditure was roughly 2.79 trillion yuan (about $441.13 billion) in 2021, rising 14.2 % per year. The new income pockets for market participants are likely to include India, Japan, Brazil, and RoAPAC. In addition, the substantial investment in bio-manufacturing infrastructure is a crucial component driving these sectors' strong development potential and are anticipated to cater to ample opportunities for single-use bioprocessing market growth in future. Market Analysis Of Different Segments Covered in the Report Based on the Product Single-use media bags and containers Single-use assemblies Single-use bioreactors Disposable mixers Other products Based on Application Filtration Mixing Purification Storage Cell culture Based on End-users Biopharmaceutical & Pharmaceutical companies Academic & Research institutes CROs & CMOS (Contract Research Organizations and contract manufacturing organizations) Regional Coverage Analysis North America The U.S. Canada Mexico Rest of North America Europe France Germany U.K Spain Italy Rest of Europe Asia Pacific China India Japan Australia Rest of APAC LAMEA Brazil Saudi Arabia South Africa Rest of LAMEA Segments Analysis & Insights Based on Products, Single-use media bags and containers significantly held the largest industry share in 2020. The market for single-use media bags is being driven by the increased usage of single-use plastic bags in biomanufacturing processes. The Single-Use Plastic market size was valued at around 40.77 Mn tons in 2020 & it’s forecasted to grow during 2020–2030 at a CAGR of 4.14%. According to the UNEP (United Nations Environment programme), by 2050, worldwide primary plastic production is expected to exceed 1,100 million tonnes. In addition, single-use bioprocessing systems have become more popular in biopharmaceutical applications due to advantages such as lesser capital investment, lower operational costs, and a smaller environmental imprint. Based on Applications, The Filtration held the largest share in 2020. It is expected to dominate the industry due to its simpler methods for manufacturing physical goods such as vaccines, monoclonal antibodies, and others. Based on End users, The biopharmaceutical and pharmaceutical companies held the largest market share in 2020. It is expected to dominate the industry as a critical method for manufacturing physical goods such as vaccines, monoclonal antibodies, and others. According to the Medical News Today, The Food and Drug Administration (FDA) granted four kinds of monoclonal antibodies an Emergency Use Authorization. Individuals with mild to severe COVID-19 symptoms can get these monoclonal antibodies up to 10 days after their symptoms first appeared.In addition, monoclonal antibodies and tailored pharmaceuticals are expected to dominate due to the rising implementation of these systems for improved production of vaccines. Based on Regions, North America dominated the industry with the largest share in 2020. In North America, the growing need for biopharmaceuticals is a primary driver of the single-use bioprocessing market. In addition, the expanding elderly population is driving up the demand for biopharmaceuticals. Moreover, the adoption of single-use bioprocessing is fuelled by the rising demand for biopharmaceuticals and the benefits of single-use bioprocessing. According to WHO, Moderna, Inc. has been allocated about US$ 480 million by the US government for the development of COVID-19 vaccines. In 2020, the Canadian government would invest roughly US$ 160 million in the development of COVID-19 vaccines and medicines. Single-use Bioprocessing Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 14.83 billion Revenue forecast in 2030 USD 56 billion Growth rate CAGR of approximately 15.86% Base year for estimation 2021 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Application, By End-User, By Region By Product single-use media bags and containers, single-use assemblies, single-use bioreactors, disposable mixers, other products By Application Filtration, Mixing, Purification, Storage, cell culture By End-User Biopharmaceutical & Pharmaceutical companies, Academic & Research institutes, CROs & CMOS By Region Asia Pacific, North America, Europe, LAMEA Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Catalent, Merck KGaA (Germany), Thermo Fisher Scientific (US), Danaher Corporation (US), Sartorius Stedim Biotech S.A. (France), Getinge AB (Sweden), Eppendorf AG (Germany), Corning (US), Avantor (US), CESCO Bioengineering Co. Ltd. (Taiwan), Entegris (US), Cellexus (UK), Distek, Inc. (US), ABEC, Inc. (US), PBS Biotech, Inc. (US), G&G Technologies (US), Solida Biotech GmbH (Germany), Able Corporation & Biott Corporation (Japan), Stobbe Pharma GmbH (Switzerland), Celltainer Biotech (Netherlands), Satake Chemical Equipment Mfg., Ltd. (Japan), Bbi-biotech GmbH (Germany), Pierre Guerin (France), Meissner Filtration Products, Inc. (US), OmniBRx Biotechnologies (India), Kuhner AG (Switzerland), etc. Single-use Bioprocessing Market Competitive Landscape Analysis The competitive landscape analysis provides information about the crucial competitors prevailing in the worldwide market environment. The comparison is performed based on overall revenue generation, market initiatives, company overview, investment in R&D, company financials, company strengths and weaknesses, global presence, production capacity, production sites and facilities, market potential, etc. Sartorius Stedim Biotech S.A. Avantor Danaher Corporation Merck KGaA Thermo Fisher Scientific Getinge AB Eppendorf AG Corning Entegris CESCO Bioengineering Co. Ltd. Cellexus PBS Biotech, Inc. Distek, Inc. ABEC, Inc. Able Corporation & Biott Corporation G&G Technologies Solida Biotech GmbH OmniBRx Biotechnologies Satake Chemical Equipment Mfg., Ltd. Stobbe Pharma GmbH Celltainer Biotech Meissner Filtration Products, Inc. Bbi-biotech GmbH Pierre Guerin Catalent Kuhner AG Recent Developments In March 2021, Thermo Fisher Scientific invested $600 million to increase its bioprocessing capabilities. This investment was undertaken to address the growing demand for vaccines and biologics. In September 2020, Thermo Fisher Scientific spent more than USD 475 million on new capabilities at its St. Louis location, including biologics development and production, cell and gene therapy capabilities, and pharma product development. In March 2020, The Biopharma business was bought successfully by Danaher from General Electric Company's Life Sciences division. Also, Captiva was regarded as an independent operating company within Danaher's Life Sciences sector. In September 2019, ABEC Inc. introduced a single-use bioreactor system with a working volume of 6,000 L, three times the industry standard maximum limit. With the launch of these CSR bioreactors, the company surpassed the threshold that it reached in 2017, of 4,900L total production volume capabilities. Thus, this company’s initiative to increase the cell culture capacity/unit of floor space enabled with the CSR can result in huge savings of facility space, capitals, and disposables costs in the future. Frequently Asked Question About This Report How big is the single-use bioprocessing market? The global single-use bioprocessing market size was $14.83 billion in 2021 and is predicted to reach $24 billion in 2022. What is the leading application segment of the Single-use Bioprocessing Market? Based on Applications, The Filtration held the largest market share in 2020. It is expected to dominate the industry as a critical method for manufacturing physical goods such as vaccines, monoclonal antibodies, and others. What is the bioprocessing market? Bioprocessing or biotechnology uses a biocatalyst such as an enzyme, microorganisms, plant cell, or animal cell in a bioreactor to produce pharmaceuticals, foods, flavours, fuels, and chemicals. Which is the largest regional market for Single-use Bioprocessing Market? Based on Regions, North America accounted for the largest share in 2020. In North America, the growing need for biopharmaceuticals is a primary driver of the single-use bioprocessing industry. In addition, the expanding elderly population is driving up demand for biopharmaceuticals. The adoption of single-use bioprocessing is fuelled by the rising demand for biopharmaceuticals and the benefits of single-use bioprocessing. What is single-use bioprocessing? Single-use bioprocessing bags and containers are employed in many bioprocessing operations. Furthermore, single-use containers are commonly employed for crucial liquid handling applications in the biopharmaceutical and biomanufacturing industries. In addition, monoclonal antibodies are manufactured using single-use bioprocessing methods. What is the average price of PRP injection systems? The average cost of PRP injection sessions in the United Kingdom is roughly £350. PRP treatments at Dynamic Regenerative Medicine cost between £150 and £250. What are the Top single-use bioprocessing companies? Some of the notable companies are Sartorius Stedim Biotech S.A. (France), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Catalent, and Merck KGaA (Germany), etc. What is the single-use bioprocessing market growth? The global single-use bioprocessing market is expected to grow at a compound annual growth rate (CAGR) of 15.86% from 2021 to 2030 to reach USD 55.78 billion by 2030. Sources https://www.ifpma.org/resource-centre/as-covid-19-vaccine-output-estimated-to-reach-over-12-billion-by-year-end-and-24-billion-by-mid-2022-innovative-vaccine-manufacturers-renew-commitment-to-support-g20-efforts-to-address-remaining-barr/ https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Highlights.pdf https://www.biopharminternational.com/view/single-use-bioprocessing-equipment-trends-and-adoption-cmos https://www.fda.gov/news-events/press-announcements/fda-expands-authorization-two-monoclonal-antibodies-treatment-and-post-exposure-prevention-covid-19 http://www.stats.gov.cn/english/PressRelease/202201/t20220127_1827065.html 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Single-use Bioprocessing Market 4.2.1 Global market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global market, by Region, 2021-2030 (USD Million) 4.4 By Product Analysis 4.4.1 Global market, By Product, 2021-2030 (USD Million) 4.5 By End-User Business Analysis 4.5.1 Global market, By End-User, 2021-2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Global market, By Application, 2021-2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 market PEST analysis 4.9.2 market Porter’s analysis 4.10 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2020) 5.11.2. Trends in Application (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Single-use media bags and containers 7.3.1. Single-use media bags and containers market, 2021-2030 (USD Million) 7.4. Single-use assemblies 7.4.1. Single-use assemblies market, 2021-2030 (USD Million) 7.5. Single-use bioreactors 7.5.1. Single-use bioreactors market, 2021-2030 (USD Million) 7.6. Disposable mixers 7.5.1. Disposable mixers market, 2021-2030 (USD Million) 7.7. Other Products 7.5.1. Other products market, 2021-2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Biopharmaceutical & Pharmaceutical companies 8.3.1. Biopharmaceutical & Pharmaceutical companies market, 2021-2030 (USD Million) 8.4. Academic & Research institutes 8.4.1. Academic & Research institutes market, 2021-2030 (USD Million) 8.5. CROs & CMOS(Contract Research Organizations and contract manufacturing organizations) 8.5.1. CROs & CMOS(Contract Research Organizations and contract manufacturing organizations) market, 2021-2030 (USD Million) 9. Global Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Filtration 9.3.1. Filtration market, 2021-2030 (USD Million) 9.4. Mixing 9.4.1. Mixing market, 2021-2030 (USD Million) 9.5. Purification 9.5.1. Purification market, 2021-2030 (USD Million) 9.6. Storage 9.6.1. Storage market, 2021-2030 (USD Million) 9.7. Cell Culture 9.7.1. Cell Culture market, 2021-2030 (USD Million) 10. Global Market: Regional Outlook 10.1 North America 10.1.1. North America market, by By Product, 2021-2030 (USD Million) 10.1.2. North America market, by By End-User, 2021-2030 (USD Million) 10.1.3. North America market, by Application, 2021-2030 (USD Million) 10.1.4. North America market, by Country, 2021-2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. market, by By Product, 2021-2030 (USD Million) 10.1.4.1.2. U.S. market, by By End-User, 2021-2030 (USD Million) 10.1.4.1.3. U.S. market, by Application, 2021-2030 (USD Million) 10.1.4.2. Canada 10.1.4.2.1. Canada market, by By Product, 2021-2030 (USD Million) 10.1.4.2.2. Canada market, by By End-User, 2021-2030 (USD Million) 10.1.4.2.3. Canada market, by Application, 2021-2030 (USD Million) 10.2. Europe 10.2.1. Europe market, by By Product, 2021-2030 (USD Million) 10.2.2. Europe Sin-use Bioprocessing market, by By End-User, 2021-2030 (USD Million) 10.2.3. Europe market, by Application, 2021-2030 (USD Million) 10.2.4. Europe market, by Country, 2021-2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. market, by By Product, 2021-2030 (USD Million) 10.2.4.1.2. U.K. market, by By End-User, 2021-2030 (USD Million) 10.2.4.1.3. U.K. market, by Application, 2021-2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany market, by By Product, 2021-2030 (USD Million) 10.2.4.2.2. Germany market, by By End-User, 2021-2030 (USD Million) 10.2.4.2.3. Germany market, by Application, 2021-2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France market, by By Product, 2021-2030 (USD Million) 10.2.4.3.2. France market, by By End-User, 2021-2030 (USD Million) 10.2.4.3.3. France market, by Application, 2021-2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe market, by By Product, 2021-2030 (USD Million) 10.2.4.4.2. Rest of Europe market, by By End-User, 2021-2030 (USD Million) 10.2.4.4.3. Rest of Europe market, by Application, 2021-2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific market, by By Product, 2021-2030 (USD Million) 10.3.2. Asia Pacific market, by By End-User, 2021-2030 (USD Million) 10.3.3. Asia Pacific market, by Application, 2021-2030 (USD Million) 10.3.4. Asia Pacific market, by Country, 2021-2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China market, by By Product, 2021-2030 (USD Million) 10.3.4.1.2. China market, by By End-User, 2021-2030 (USD Million) 10.3.4.1.3. China market, by Application, 2021-2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India market, by By Product, 2021-2030 (USD Million) 10.3.4.2.2. India market, by By End-User, 2021-2030 (USD Million) 10.3.4.2.3. India market, by Application, 2021-2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan market, by By Product, 2021-2030 (USD Million) 10.3.4.3.2. Japan market, by By End-User, 2021-2030 (USD Million) 10.3.4.3.3. Japan market, by Application, 2021-2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea market, by By Product, 2021-2030 (USD Million) 10.3.4.4.2. South Korea market, by By End-User, 2021-2030 (USD Million) 10.3.4.4.3. South Korea market, by Application, 2021-2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC market, by By Product, 2021-2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC market, by By End-User, 2021-2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC market, by Application, 2021-2030 (USD Million) 10.4. Latin America 10.4.1. Latin America market, by By Product, 2021-2030 (USD Million) 10.4.2. Latin America market, by By End-User, 2021-2030 (USD Million) 10.4.3. Latin America market, by Application, 2021-2030 (USD Million) 10.4.4. Latin America market, by Country, 2021-2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil market, by By Product, 2021-2030 (USD Million) 10.4.4.1.2. Brazil market, by By End-User, 2021-2030 (USD Million) 10.4.4.1.3. Brazil market, by Application, 2021-2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico market, by By Product, 2021-2030 (USD Million) 10.4.4.2.2. Mexico market, by By End-User, 2021-2030 (USD Million) 10.4.4.2.3. Mexico market, by Application, 2021-2030 (USD Million) 10.4.4.3. Rest of the Latin America 10.4.4.3.1. Rest of the Latin America market, by By Product, 2021-2030 (USD Million) 10.4.4.3.2. Rest of the Latin America market, by By End-User, 2021-2030 (USD Million) 10.4.4.3.3. Rest of the Latin America market, by Application, 2021-2030 (USD Million) 10.5. MEA 10.5.1. MEA market, by By Product, 2021-2030 (USD Million) 10.5.2. MEA market, by By End-User, 2021-2030 (USD Million) 10.5.3. MEA market, by Application, 2021-2030 (USD Million) 10.5.4. MEA market, by Region, 2021-2030 (USD Million) 11. Competitive Landscape 11.1 Sartorius Stedim Biotech S.A. 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. Product Portfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. DANAHER CORPORATION (U.S.) 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. THERMO FISHER SCIENTIFIC INC. (U.S.) 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. MERCK KGAA (GERMANY). 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. CATALENT 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development List of Tables (43 Tables) TABLE 1. MARKET, By Product, 2021-2030 (USD Million) TABLE 2. MARKET FOR Single-use media bags and containers, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Single-use assemblies, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Single-use bioreactors, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET FOR Disposable mixers, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR Other products, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET, By End-User, 2021-2030 (USD Million) TABLE 8. MARKET FOR Biopharmaceutical & Pharmaceutical companies, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET FOR Academic & Research institutes, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET FOR CROs & CMOS(Contract Research Organizations and contract manufacturing organizations), BY REGION, 2021-2030 (USD Million) TABLE 11. MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Filtration, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Mixing, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET FOR Purification, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Storage, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET FOR Cell Culture, BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 18. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 19. NORTH AMERICA MARKET, By Product, 2021-2030 (USD Million) TABLE 20. NORTH AMERICA MARKET, By End-User, 2021-2030 (USD Million) TABLE 21. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 22. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 23. EUROPE MARKET, By Product, 2021-2030 (USD Million) TABLE 24. EUROPE MARKET, By End-User, 2021-2030 (USD Million) TABLE 25. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 26. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 27. ASIA-PACIFIC MARKET, By Product, 2021-2030 (USD Million) TABLE 28. ASIA-PACIFIC MARKET, By End-User, 2021-2030 (USD Million) TABLE 29. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 30. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 31. LAMEA MARKET, By Product, 2021-2030 (USD Million) TABLE 32. LAMEA MARKET, By End-User, 2021-2030 (USD Million) TABLE 33. LAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 34. Sartorius Stedim Biotech S.A.: COMPANY SNAPSHOT TABLE 35. Sartorius Stedim Biotech S.A.: OPERATING SEGMENTS TABLE 36. DANAHER CORPORATION (U.S.): COMPANY SNAPSHOT TABLE 37. DANAHER CORPORATION (U.S.): OPERATING SEGMENTS TABLE 38. THERMO FISHER SCIENTIFIC INC. (U.S.): COMPANY SNAPSHOT TABLE 39. THERMO FISHER SCIENTIFIC INC. (U.S.): OPERATING SEGMENTS TABLE 40. MERCK KGAA (GERMANY). : COMPANY SNAPSHOT TABLE 41. MERCK KGAA (GERMANY). : OPERATING SEGMENTS TABLE 42. CATALENT: COMPANY SNAPSHOT TABLE 43. CATALENT: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 5 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Single-use Bioprocessing, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Single-use Bioprocessing, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Biopharmaceutical & Pharmaceutical companies Market, By End-User, 2019 vs 2025 (USD Million) Figure 12 Filtration Market Share, By Application, 2019 vs 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 single-use media bags and containers to Witness Higher CAGR in the Market for Product Segment during Forecast Period. Figure 16 Filtration to Witness Higher CAGR in the Market for Application Segment during Forecast Period. Figure 17 Biopharmaceutical & Pharmaceutical companies to Witness Higher CAGR in the Market for End-User Segment during Forecast Period. Figure 18 North America region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview